- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06385938
Ultrasound Imaging and Quantitative Vibro-Acoustic Assessment of Rickets Under the Age of Ten
December 12, 2024 updated by: Thomas Thacher, Mayo Clinic
Ultrasound Imaging and Quantitative Vibro-acoustic Assessment of Rickets in Children
The goal of this study is to find out if the use of ultrasound pictures of bones can spot changes in the growth areas of children with rickets, a condition that affects how bones harden.
Researchers want to see if these ultrasound pictures can help tell the difference between children who have rickets and those who don't.
Study Overview
Status
Withdrawn
Conditions
Intervention / Treatment
Detailed Description
Aims, purpose, or objectives:
- To determine if ultrasound imaging of bone can identify the changes of impaired mineralization of the growth plates at the wrists and the knees, similar to those visible on plain radiographs.
- To determine if quantitative vibro-acoustic measurements of the bone in subjects with rickets significantly differs from control subjects, matched for age, sex, and BMI.
- To determine the relationship of ultrasound images and quantitative vibro-acoustic assessment with rickets severity score (RSS), based on radiographs of the wrists and knees.
- To determine if longitudinal changes in ultrasound images and quantitative vibro-acoustic assessment with treatment of rickets are related to changes in the rickets severity score.
Study Type
Observational
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Minnesota
-
Rochester, Minnesota, United States, 55905
- Recruiting
- Mayo Clinic Minnesota
-
Contact:
- Mary A Johnson
- Phone Number: 507-422-6823
- Email: johnson.mary15@mayo.edu
-
Principal Investigator:
- Tom D. Thacher, MD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Yes
Sampling Method
Non-Probability Sample
Study Population
Prepubertal children <10 years of age at enrollment with active nutritional or genetic rickets recruited from the Mayo Clinic Pediatric Endocrinology Bone Clinic or from the Mayo Clinic outpatient or inpatient services in Rochester, MN (cases).
Healthy matched control children will be recruited from children empaneled in Mayo Clinic primary care (Family Medicine or Community Pediatrics).
Description
Inclusion Criteria:
- Cases: Prepubertal children less than 10 years of age with active nutritional or genetic rickets at enrollment (RSS>1.5 based on radiographs of the wrists and knees performed within 3 months prior to enrollment). Cases will be recruited from the Pediatric Endocrinology Bone Clinic or from the Mayo Clinic outpatient or inpatient services in Rochester, MN. Cases who return for follow-up and demonstrate improvement in RSS≥1.0 will be eligible for a single repeat ultrasound evaluation.
- Controls: Healthy children empaneled in Mayo Clinic primary care (Family Medicine or Community Pediatrics) matched for age (±3 months), sex, and BMI (±0.5 kg/m2)
Exclusion Criteria:
- Known fracture at imaging site
- Rickets of prematurity
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Children with Active Rickets Group
Children under 10 years of age with a diagnosis of active rickets on radiographs of the wrists and knees will undergo ultrasound imaging and quantitative vibro-acoustic assessment.
|
Imaging with non-invasive bone assessment based on wide range of frequencies and free from soft tissue artifact of the wrists and the knees
|
|
Healthy Children Control Group
Healthy children under 10 years of age not diagnosed with rickets, but match the age, gender, and weight of the children with rickets, will undergo ultrasound imaging and quantitative vibro-acoustic assessment.
|
Imaging with non-invasive bone assessment based on wide range of frequencies and free from soft tissue artifact of the wrists and the knees
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Relationship of quantitative vibro-acoustic ultrasound and rickets severity score
Time Frame: Baseline
|
Quantitative vibro-acoustic data will be compared with the radiographic rickets severity score to assess if ultrasound measures are reliably related to the radiographic findings.
|
Baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Relationship of ultrasound images with radiographic evidence of rickets
Time Frame: Baseline
|
Determine if ultrasound imaging of bone can identify the changes of impaired mineralization of the growth plates at the wrists and the knees, similar to those visible on plain radiographs
|
Baseline
|
|
Case-control comparison of quantitative vibro-acoustic ultrasound measurements between children with rickets and control subjects
Time Frame: Baseline
|
2. To determine if quantitative vibro-acoustic measurements of the bone in subjects with rickets significantly differs from control subjects, matched for age, sex, and BMI.
|
Baseline
|
|
Longitudinal changes in vibro-acoustic ultrasound measurements with treatment of rickets
Time Frame: Baseline
|
To determine if longitudinal changes in ultrasound images and quantitative vibro-acoustic assessment with treatment of rickets are related to changes in the rickets severity score
|
Baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Thomas D Thacher, MD, Mayo Clinic
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 13, 2024
Primary Completion (Actual)
December 5, 2024
Study Completion (Actual)
December 5, 2024
Study Registration Dates
First Submitted
April 18, 2024
First Submitted That Met QC Criteria
April 23, 2024
First Posted (Actual)
April 26, 2024
Study Record Updates
Last Update Posted (Actual)
March 25, 2025
Last Update Submitted That Met QC Criteria
December 12, 2024
Last Verified
December 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 23-012048
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Rickets
-
Bicetre HospitalCompletedX Linked Hypophosphatemic Rickets
-
Yale UniversityNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)CompletedHypophosphatemic Rickets, X Linked DominantUnited States
-
Kyowa Kirin Co., Ltd.CompletedX-linked Hypophosphatemic Rickets/OsteomalaciaJapan
-
Kyowa Kirin Co., Ltd.CompletedX-linked Hypophosphatemic Rickets/OsteomalaciaJapan, Korea, Republic of
-
Zeria PharmaceuticalCompletedPrimary Hypophosphatemic RicketsJapan
-
Hospices Civils de LyonNot yet recruitingX-Linked Hypophosphatemic Rickets
-
Inozyme PharmaBioMarin PharmaceuticalRecruitingAutosomal Recessive Hypophosphatemic Rickets | Ectonucleotide Pyrophosphatase/phosphodiesterase1 Deficiency | Generalized Arterial Calcification of Infancy 1France, United Kingdom, Italy, Saudi Arabia, Brazil, Hungary, Spain, Turkey (Türkiye)
-
Kyowa Kirin Co., Ltd.CompletedA Study of KRN23 in Adult and Pediatric Patients With X-linked Hypophosphatemic Rickets/OsteomalaciaXLHJapan, Korea, Republic of
-
Indiana UniversityCompletedAutosomal Dominant Hypophosphatemic RicketsUnited States
-
Inozyme PharmaEngage Health Inc.; GACI GlobalCompletedGeneralized Arterial Calcification in Infancy | Autosomal Recessive Hypophosphatemic Rickets Type 2United States
Clinical Trials on Ultrasound with quantitative vibro-acoustic assessment
-
Mayo ClinicNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and other collaboratorsCompletedOsteopenia | Metabolic Bone Disease | Neonatal RicketsUnited States
-
Ain Shams UniversityCompletedBone Mineral Density Quantitative Trait Locus 3Egypt
-
Rocky Vista University, LLCAmerican Osteopathic AssociationEnrolling by invitationChronic Neck PainUnited States
-
University of MichiganChildren's Hospital Medical Center, CincinnatiCompletedLiver FibrosesUnited States
-
Hospices Civils de LyonCompletedPulmonary Aspiration of Gastric ContentsFrance
-
Massachusetts General HospitalGE HealthcareCompletedFatty Liver | Nonalcoholic Steatohepatitis | Nonalcoholic Fatty LiverUnited States
-
University of MichiganCompleted
-
Washington University School of MedicineMidwest Stone Institute.CompletedUreteral CalculiUnited States
-
Washington University School of MedicineCompletedSleep | Sedation ComplicationUnited States
-
Keller Fire RescueUnknownKidney Calculi | Pregnancy | Multiple Trauma | Ultrasonography | Aortic Aneurysm, Abdominal | Catheterization, VenousUnited States